E148 - 147_Where Are We With Cannabis Medicine?

Today on The Mary Jane Society, we're joined by Shane Johnson, a Stanford-trained medical doctor and accomplished biotech entrepreneur. Shane is the co-founder of BayMedica, a pioneering manufacturer of rare and minor cannabinoid ingredients known for their exceptional purity, consistency, and scalability traits critical to the future of pharmaceutical-grade cannabinoid products.

BayMedica was acquired by InMed Pharmaceuticals, a NASDAQ-listed, clinical-stage pharmaceutical company based in Canada. InMed is developing a robust pipeline of proprietary small molecule drug candidates that target the CB1 and CB2 receptors of the endocannabinoid system. Their current research programs focus on therapeutic t...